Skip to content
About
About Bionomics
Executive Leadership
Board of Directors
Clinical Advisory Board
Pipeline
Our Pipeline
BNC210 (α7 nAChR NAM)
α7 nAChR (PAM)
Pre-Clinical CNS
Publications
Prior Clinical Trials
Partners
Partners
Legacy Oncology
Investor Center
Overview
News & Events
News Releases
Events
Corporate Presentations
Stock Information
Stock Quote & Chart
Historical Price Lookup
Investment Calculator
Analyst Coverage
Corporate Governance
Documents & Charters
Executive Leadership
Board of Directors
Committee Composition
Financials & Filings
SEC Filings
ASX Announcements
Company Reporting
Shareholders Meetings
IR Resources
Share Ownership
Email Alerts
Contact IR
Contact Us
General Enquiries
Partnership Enquiries
About
About Bionomics
Executive Leadership
Board of Directors
Clinical Advisory Board
Pipeline
Our Pipeline
BNC210 (α7 nAChR NAM)
α7 nAChR (PAM)
Pre-Clinical CNS
Publications
Prior Clinical Trials
Partners
Partners
Legacy Oncology
Investor Center
Overview
News & Events
News Releases
Events
Corporate Presentations
Stock Information
Stock Quote & Chart
Historical Price Lookup
Investment Calculator
Analyst Coverage
Corporate Governance
Documents & Charters
Executive Leadership
Board of Directors
Committee Composition
Financials & Filings
SEC Filings
ASX Announcements
Company Reporting
Shareholders Meetings
IR Resources
Share Ownership
Email Alerts
Contact IR
Contact Us
General Enquiries
Partnership Enquiries
PAPERS & POSTERS
BNC210
Cholinergic modulation of disorder-relevant human defensive behaviour in generalised anxiety disorder
1 Jan 2021
Download
(957Kb)
(957Kb)
Cholinergic Modulation of Disorder-Relevant Neural Circuits in Generalized Anxiety Disorder
1 May 2020
Download
(595Kb)
(595Kb)
α7 Receptor PAM
Discovery of BNC375, a Potent, Selective, and Orally Available Type I Positive Allosteric Modulator of α7 nAChRs
31 Dec 2018
Download
(943Kb)
(943Kb)